Scientists have developed a totally implantable cochlear implant that delivers hearing performance comparable to conventional devices while improving quality of life and eliminating the need for external components.
Novo Nordisk enters deal to develop therapies for obesity
The companies will partner to develop multitarget therapies that act on the GLP-1 receptor. Credit: Hunterframe / Shutterstock.com. Novo Nordisk has entered a research partnership